Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048501 · ClinicalTrials.gov registry record · NA
Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02048501 is a NA study that has completed, run by Duke University. The registered enrollment target is 57 participants.
The verdict
NCT02048501, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to gain a better understanding of the mechanism of weight regain through gut hormone (substances in the gut that control various functions of the digestive organs) and energy expenditure (the amount of energy a person uses to complete bodily activities). Our hypothesis is that gut hormone response might be different among subjects who are able to maintain weight loss and subjects with weight regain. For this study, investigators will measure fasting and postprandial (happening after a meal) gut hormones, bile acid, amino acids, vitamin B, vitamin D, myokines and adipokine levels in obese individuals who are at least 2 years after a Roux-en-Y gastric bypass (RYGB). Investigators will also measure resting metabolic rate (RMR) (the amount of energy expended daily) and body composition (the proportion of fat, muscle, and bone of an individual's body). The subjects body composition will be analyzed, including fat mass and fat free mass, by a Dual-Energy X-ray Absorptiometry (DEXA). This study will provide more information regarding the effect of RYGB on gut hormones, adipokines, bile acids, amino acids, and energy expenditure and body compositions.
Interventions
- OTHER Resting Metabolic Rate (RMR)
- OTHER Duel-energy x-ray absorptiometry (DEXA)
- OTHER Visual Analog Scale (VAS)
- OTHER Meal Stimulation Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02048501
The ClinicalTrials.gov registry entry for NCT02048501 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Resting Metabolic Rate (RMR) is the first listed.
NCT02048501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02048501 about?
NCT02048501 is a clinical study titled "Changes in Gut Hormones, Body Composition and Energy Expenditure After Roux-en-Y". The purpose of this study is to gain a better understanding of the mechanism of weight regain through gut hormone (substances in the gut that control various functions of the digestive organs) and energy expenditure (the amount of energy a person uses to complete bodily activities). Our hypothesis ...
What is the current status of trial NCT02048501?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2014-01. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02048501?
The interventions under investigation include: Resting Metabolic Rate (RMR) (OTHER), Duel-energy x-ray absorptiometry (DEXA) (OTHER), Visual Analog Scale (VAS) (OTHER), Meal Stimulation Test (OTHER).
Who is sponsoring clinical trial NCT02048501?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.